I could list 10 examples of the opposite where very much less promising biotechs got bought out for 20x 30x 40x of there 52 week low. Sky is the limit but need fo have patience, also never know when a big pharma will have enough data to pull the trigger on buyout or strategic partnership could be a month from now or many years either way ill be holding and adding. Cydy isnt going anywhere top notch scientific board, solid management and a new ceo with very decorated past. Once clinical hold is dropped i can see this company taking all the promise it has over seas to be used and bring in big revenue possibly way before an fda approval. Lets not forget all the recognition and worldwide relationships that were made because of our covid-19 eind’s and trials.